Literature DB >> 20483489

Identification of two novel mutations, c.232T>C and c.2006A>T, in SLC26A4 in a Chinese family associated with enlarged vestibular aqueduct.

Yu-Fen Guo1, Yan-Li Wang, Bai-Cheng Xu, Xiao-Wen Liu, Yi-Ming Zhu, Fei-Fan Zhao, Yu-Bin Ji, Ying Zhou, Jian-Qiang Li, Qian Li, Da-Yong Wang, Qiu-Ju Wang.   

Abstract

It is known that enlarged vestibular aqueduct syndrome is closely related to the SLC26A4 mutation. Up to date, more than 200 of SLC26A4 mutations have been described, and novel mutations are being continually identified in different countries and ethnic groups. In this study, two novel variations were identified in a Chinese family associated with enlarged vestibular aqueduct. The two novel substitutions, c.232T>C and c.2006A>T, were detected in exon 3 and exon 17 of the pendrin encoding gene, respectively. The T/C transversion at 232 nucleotide caused p.Y78H mutation while the A/T transversion at 2006 nucleotide caused p.D669V mutation. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483489     DOI: 10.1016/j.ijporl.2010.04.005

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  Strategies for genetic study of hearing loss in the Brazilian northeastern region.

Authors:  Uirá S Melo; Silvana Santos; Hannalice G Cavalcanti; Wagner T Andrade; Vitor G Dantas; Marine Rd Rosa; Regina C Mingroni-Netto
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

2.  Vestibular Dysfunction in Patients with Enlarged Vestibular Aqueduct.

Authors:  Chris K Zalewski; Wade W Chien; Kelly A King; Julie A Muskett; Rachel E Baron; John A Butman; Andrew J Griffith; Carmen C Brewer
Journal:  Otolaryngol Head Neck Surg       Date:  2015-05-12       Impact factor: 3.497

3.  Familial pattern of large vestibular aqueduct syndrome in a Chinese family.

Authors:  Mohd Hazmi; A Ab Aziz; A Asma
Journal:  EXCLI J       Date:  2013-02-15       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.